Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia

New England Journal of Medicine

Volumn 367, Issue 21, 2012, Pages 2055-2056

  Lisman, Ton ^a   Porte, Robert J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ELTROMBOPAG; VON WILLEBRAND FACTOR;

BLOOD TRANSFUSION; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; INVASIVE PROCEDURE; LETTER; LIVER CIRRHOSIS; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

EID: 84869481395     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1211471     Document Type: Letter

References (4)

1. Afdhal NH, Giannini EG, Tayyab G, et al. Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia. N Engl J Med 2012;367:716-24.
2. Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N Engl J Med 2011;365:147-56.
3. Lisman T, Porte RJ. Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences. Blood 2010;116:878-85.
4. Lisman T, Bongers TN, Adelmeijer J, et al. Elevated levels of von Willebrand factor in cirrhosis support platelet adhesion despite reduced functional capacity. Hepatology 2006;44:53-61.